Trials / Completed
CompletedNCT04803240
Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 310 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Multi-centre, international, non-interventional, prospective survey
Detailed description
To assess after 84 days, on a large scale patient population, the evaluation of ocular surface diseases and the satisfaction of dry eye disease (DED) treatment naïve patients or those who had to switch for tolerance, dissatisfaction or efficacy reasons to Thealoz® Duo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thealoz Duo | Non applicable |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-12-30
- Completion
- 2020-03-30
- First posted
- 2021-03-17
- Last updated
- 2021-03-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04803240. Inclusion in this directory is not an endorsement.